Thursday, July 27, 2006

Bristol-Myers Excuse Me!

Bristol-Myers Squibb Company (NYSE: BMY) reported financial results for the second quarter and six months. Tucked away in the guidance was this surprising announcement. “The company learned yesterday that the Antitrust Division of the United States Department of Justice is conducting a criminal investigation regarding the proposed settlement of the Apotex litigation described above.” Criminal investigations have a way of stopping civil matters as everyone heads for the hills.